Yasuhiro Takeshima

5.5k total citations
194 papers, 3.5k citations indexed

About

Yasuhiro Takeshima is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Yasuhiro Takeshima has authored 194 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Molecular Biology, 44 papers in Genetics and 25 papers in Physiology. Recurrent topics in Yasuhiro Takeshima's work include Muscle Physiology and Disorders (94 papers), RNA Research and Splicing (63 papers) and RNA modifications and cancer (43 papers). Yasuhiro Takeshima is often cited by papers focused on Muscle Physiology and Disorders (94 papers), RNA Research and Splicing (63 papers) and RNA modifications and cancer (43 papers). Yasuhiro Takeshima collaborates with scholars based in Japan, Singapore and United States. Yasuhiro Takeshima's co-authors include Masafumi Matsuo, Mariko Yagi, Hisahide Nishio, Hiroyuki Awano, Hiroko Wada, Hajime Nakamura, Zhujun Zhang, Yo Okizuka, Tomoko Lee and Kazumoto Iijima and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yasuhiro Takeshima

190 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuhiro Takeshima Japan 31 2.7k 743 496 451 388 194 3.5k
Takayuki Morisaki Japan 34 2.1k 0.8× 259 0.3× 747 1.5× 645 1.4× 767 2.0× 154 3.7k
Thomas P. Zwaka United States 24 3.3k 1.2× 240 0.3× 502 1.0× 477 1.1× 859 2.2× 47 4.9k
Ulrike Schara Germany 35 1.8k 0.7× 873 1.2× 279 0.6× 307 0.7× 543 1.4× 148 3.3k
May Christine V. Malicdan United States 29 1.5k 0.6× 286 0.4× 544 1.1× 309 0.7× 157 0.4× 126 2.6k
Denis Calise France 31 1.2k 0.4× 593 0.8× 217 0.4× 627 1.4× 1.0k 2.6× 74 3.4k
Dorothy K. Grange United States 36 2.1k 0.8× 220 0.3× 1.1k 2.3× 232 0.5× 372 1.0× 141 4.1k
Philippe M. Campeau Canada 33 1.8k 0.7× 412 0.6× 1.0k 2.1× 92 0.2× 303 0.8× 123 3.3k
Laurent Gouya France 35 2.9k 1.1× 339 0.5× 486 1.0× 233 0.5× 113 0.3× 116 4.1k
Mary Anna Venneri Italy 30 2.6k 1.0× 348 0.5× 550 1.1× 260 0.6× 342 0.9× 71 5.3k
John C. Fyfe United States 25 1.3k 0.5× 331 0.4× 667 1.3× 84 0.2× 436 1.1× 52 2.9k

Countries citing papers authored by Yasuhiro Takeshima

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Takeshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Takeshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Takeshima more than expected).

Fields of papers citing papers by Yasuhiro Takeshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Takeshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Takeshima. The network helps show where Yasuhiro Takeshima may publish in the future.

Co-authorship network of co-authors of Yasuhiro Takeshima

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Takeshima. A scholar is included among the top collaborators of Yasuhiro Takeshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Takeshima. Yasuhiro Takeshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeshima, Yasuhiro. (2025). Expansion of Splice-Switching Therapy with Antisense Oligonucleotides. International Journal of Molecular Sciences. 26(5). 2270–2270. 2 indexed citations
2.
Awano, Hiroyuki, Tetsushi Yamamoto, Tomoko Lee, et al.. (2024). Longitudinal data of serum creatine kinase levels and motor, pulmonary, and cardiac functions in 337 patients with Duchenne muscular dystrophy. Muscle & Nerve. 69(5). 604–612. 2 indexed citations
3.
Shimomura, Hideki, Naoko Taniguchi, Yohei Taniguchi, et al.. (2024). Cyproheptadine Treatment in Children and Adolescents with Migraine: A Retrospective Study in Japan. Neurology International. 16(6). 1308–1317.
4.
Shimomura, Hideki, Naoko Taniguchi, Kumiko Yanagi, et al.. (2024). A novel DLG4 variant causes DLG4-related synaptopathy with intellectual regression. Human Genome Variation. 11(1). 1–1. 3 indexed citations
5.
Okuda, Masumi, et al.. (2023). Relationship between growth and food avoidance with food allergy at age 3 years: The Japan Environment and Children's Study (JECS). World Allergy Organization Journal. 16(10). 100826–100826. 3 indexed citations
6.
Shimomura, Hideki, et al.. (2023). A Pediatric Case of COLQ-Related Congenital Myasthenic Syndrome with Marked Fatigue. Children. 10(5). 769–769.
7.
Nishio, Hisahide, Emma Tabe Eko Niba, Toshio Saito, et al.. (2023). Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. International Journal of Molecular Sciences. 24(15). 11939–11939. 56 indexed citations
8.
Lee, Tomoko, Naoko Taniguchi, Hideki Shimomura, et al.. (2021). Underlying diseases in sporadic presentation of high creatine kinase levels in girls. Clinica Chimica Acta. 519. 198–203. 3 indexed citations
9.
Shimomura, Hideki, Tomoko Lee, Yasuhiko Tanaka, et al.. (2019). Two closely spaced mutations in cis result in Ullrich congenital muscular dystrophy. Human Genome Variation. 6(1). 21–21. 2 indexed citations
10.
Niba, Emma Tabe Eko, Văn Khanh Trần, Dũng Chí Vũ, et al.. (2014). Validation of ambiguous MLPA results by targeted next-generation sequencing discloses a nonsense mutation in the DMD gene. Clinica Chimica Acta. 436. 155–159. 11 indexed citations
11.
Takeshima, Yasuhiro, Mariko Yagi, & Masafumi Matsuo. (2012). Optimizing RNA/ENA Chimeric Antisense Oligonucleotides Using In Vitro Splicing. Methods in molecular biology. 867. 131–141. 6 indexed citations
12.
Sólyom, Szilvia, Adam D. Ewing, Dustin C. Hancks, et al.. (2011). Pathogenic orphan transduction created by a nonreference LINE-1 retrotransposon. Human Mutation. 33(2). 369–371. 32 indexed citations
13.
Takeshima, Yasuhiro, Atsushi Nishida, Hiroyuki Awano, et al.. (2011). A G-to-T Transversion at the Splice Acceptor Site of Dystrophin Exon 14 Shows Multiple Splicing Outcomes That Are Not Exemplified by Transition Mutations. Genetic Testing and Molecular Biomarkers. 16(1). 3–8. 1 indexed citations
14.
Saito, Toshio, Naoko Sasaki, Gunadi Gunadi, et al.. (2011). Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines. Brain and Development. 34(3). 213–222. 29 indexed citations
15.
Nakagawa, Taku, Satoru Morikawa, Ichiro Morioka, et al.. (2011). A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome.. PubMed. 57(1). E26–31. 6 indexed citations
16.
Takeshima, Yasuhiro, Mariko Yagi, Yo Okizuka, et al.. (2010). Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. Journal of Human Genetics. 55(6). 379–388. 188 indexed citations
17.
Matsuo, Masafumi & Yasuhiro Takeshima. (2009). [Mutation-specific treatments for Duchenne muscular dystrophy].. PubMed. 61(8). 915–22. 1 indexed citations
18.
Okizuka, Yo, Yasuhiro Takeshima, Hiroyuki Awano, et al.. (2009). Small Mutations Detected by Multiplex Ligation-Dependent Probe Amplification of the Dystrophin Gene. Genetic Testing and Molecular Biomarkers. 13(3). 427–431. 16 indexed citations
19.
20.
Adachi, Kayo, Yasuhiro Takeshima, Hiroko Wada, et al.. (2003). Heterogous Dystrophin mRNA Produced by a Novel Splice Acceptor Site Mutation in Intermediate Dystrophinopathy. Pediatric Research. 53(1). 125–131. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayuki Morisaki Breakdown of academic impact, for papers by Thomas P. Zwaka Breakdown of academic impact, for papers by Ulrike Schara Breakdown of academic impact, for papers by May Christine V. Malicdan Breakdown of academic impact, for papers by Denis Calise Breakdown of academic impact, for papers by Dorothy K. Grange Breakdown of academic impact, for papers by Philippe M. Campeau Breakdown of academic impact, for papers by Laurent Gouya Breakdown of academic impact, for papers by Mary Anna Venneri Breakdown of academic impact, for papers by John C. Fyfe
Rankless by CCL
2026